{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:07:23Z","timestamp":1793984843353,"version":"4.8.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.eururo.2020.08.018","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T08:11:07Z","timestamp":1598602267000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction"],"prefix":"10.1016","volume":"80","author":[{"given":"Gaetano","family":"de Rienzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-4375","authenticated-orcid":false,"given":"Paolo","family":"Minafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Zingarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Papapicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Ditonno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eururo.2020.08.018_bib0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.urology.2011.11.084","article-title":"National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008)","volume":"79","author":"Malaeb","year":"2012","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.eururo.2020.08.018_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/UA.UA_99_18","article-title":"Evaluation of outcome of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia: A 10-year experience","volume":"11","author":"Haroun","year":"2019","journal-title":"Urol Ann"},{"issue":"January","key":"10.1016\/j.eururo.2020.08.018_bib0015","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","author":"McVary","year":"2019","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.eururo.2020.08.018_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia","volume":"10","author":"Westwood","year":"2018","journal-title":"Ther Adv Urol."},{"issue":"7","key":"10.1016\/j.eururo.2020.08.018_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11934-019-0903-7","article-title":"What\u2019s new in Rezum: a transurethral water vapour therapy for BPH","volume":"20","author":"Green","year":"2019","journal-title":"Curr Urol Rep"},{"issue":"6","key":"10.1016\/j.eururo.2020.08.018_bib0030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","article-title":"Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up","volume":"123","author":"Porpiglia","year":"2019","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.eururo.2020.08.018_bib0035","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"issue":"April","key":"10.1016\/j.eururo.2020.08.018_bib0040","article-title":"Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia","author":"Insausti","year":"2020","journal-title":"J Vasc Interv Radiol JVIR"},{"issue":"December","key":"10.1016\/j.eururo.2020.08.018_bib0045","article-title":"Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study","author":"Pacella","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.eururo.2020.08.018_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00345-010-0566-y","article-title":"The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate","volume":"29","author":"Mamoulakis","year":"2011","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.eururo.2020.08.018_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.08.018_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12894-015-0090-x","article-title":"Patient\u2019s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?","volume":"15","author":"Cindolo","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2020.08.018_bib0065","unstructured":"Gravas S., Cornu J.-N., Gacci M., et al. EAU-Guidelines-on-the-Management-of-Non-Neurogenic-Male-LUTS-2019. Uroweb. https:\/\/uroweb.org\/guideline\/treatment-of-non-neurogenic-male-luts\/. Accessed April 8, 2020."},{"issue":"3","key":"10.1016\/j.eururo.2020.08.018_bib0070","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2011.04.068","article-title":"Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia","volume":"186","author":"Chung","year":"2011","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eururo.2020.08.018_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000282628","article-title":"A new theory of micturition and urinary continence based on histomorphological studies. 5. The musculus ejaculatorius: a newly described structure responsible for seminal emission and ejaculation","volume":"53","author":"Dorschner","year":"1994","journal-title":"Urol Int."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820306357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820306357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:08:42Z","timestamp":1759583322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283820306357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0302283820306357"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2020.08.018","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2020.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}